Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

Participants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

However, a study suggests that focusing on the time you spend exercising instead of your number of steps may be just as ...

RCMP now say it looks like one of two vehicles involved in a crash on Highway 101 on Saturday night that killed five people was driving the wrong way on the divided highway. An act booked for the ...